[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Arcellx, Inc. Common Stock (ACLX)
Arcellx shares surge following positive Phase X trial data for anito-cel, with analysts upgrading ratings and the company confirming a 2026 launch plan after a pre-BLA meeting with the FDA.
About Arcellx, Inc. Common Stock
Arcellx, Inc. is a biopharmaceutical company focused on developing novel cancer therapies.
Arcellx, Inc. Common Stock uses the ticker $ACLX for trading. Listed in the Stocks category within the Healthcare sectors.
Insights
- Arcellx, Inc. Common Stock (ACLX) social dominance hit XXXXXX which is XXX% higher than it's daily average.
- Arcellx, Inc. Common Stock (ACLX) trading volume is up XXXXXX% from the previous month.
- Arcellx, Inc. Common Stock (ACLX) social dominance is up XXXXXX% from the previous X months.
- Arcellx, Inc. Common Stock (ACLX) Galaxy Score™ is up XX% from the previous week.
- Arcellx, Inc. Common Stock (ACLX) sentiment is up XXXXX% from the previous X months.
- Arcellx, Inc. Common Stock (ACLX) creators is up XXXXXX% from the previous month.
- Arcellx, Inc. Common Stock (ACLX) engagements is up XXXXXX% from the previous month.
- Arcellx, Inc. Common Stock (ACLX) mentions is up XXXXXX% from the previous month.
- Arcellx, Inc. Common Stock (ACLX) posts created is up XXXXXX% from the previous week.
- Arcellx, Inc. Common Stock Engagements hit a 52-Week high of XXXXXX for the day
Price: $XXXXX
Price 24-Hour Time-Series Raw Data
The stock price is experiencing upward pressure due to positive Phase X trial data and analyst upgrades, despite some concerns about overall engagement levels.
24-Hour: XXXX% 7-Day: -XXXX% 30-Day: -XXXXX%
1-Year High: $XXXXX on 2025-10-15
1-Year Low: $XXXXX on 2025-05-06
AltRank: XXX
AltRank 24-Hour Time-Series Raw Data
Arcellx, Inc. Common Stock (ACLX) is currently AltRank #672 based on combined combined social and market metrics
Daily Average: XXXXX
X Week: XXXXX +796
X Month: XXXXX +240
X Months: XXXXX +633
X Year: XXXXX +663
1-Year High: XXXXX on 2025-07-18
1-Year Low: XX on 2025-05-29
Galaxy Score: XXXXX
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX +16
X Month: XX -XX
X Months: XX -XX
X Year: XX -X
1-Year High: XX on 2025-03-03
1-Year Low: XX on 2025-07-19
Engagements: XXXXX (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XXXXX
X Week: XXXXXX +85%
X Month: XXXXXXX +483%
X Months: XXXXXXX -XX%
X Year: XXXXXXXXX -XXXX%
1-Year High: XXXXXX on 2025-12-07
1-Year Low: XX on 2025-09-15
Engagements by network (24h): Reddit: XX X: XXXXX YouTube: XX
Mentions: XXX (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XX
X Week: XXX +60%
X Month: XXX +116%
X Months: XXXXX +35%
X Year: XXXXX +74%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-09-15
Mentions by network (24h): Reddit: XX X: XXX YouTube: X
Creators: XX (24h)
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Arcellx, Inc. Common Stock (ACLX) in the last XX hours which is down XX% from XXX in the previous XX hours
Daily Average: XX
X Week: XXX +70%
X Month: XXX +113%
X Months: XXXXX +105%
X Year: XXXXX +109%
1-Year High: XXX on 2025-06-29
1-Year Low: X on 2025-09-14
The most influential creators that mention Arcellx, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @BiopharmIQ | X | XXXXXX | X | XXX |
| @JacobPlieth | X | XXXXXX | X | XXX |
| @arcellx | X | XXX | X | XXX |
| @adamfeuerstein | X | XXXXXXX | X | XX |
| @ParadiseTraderr | X | XXX | X | XX |
| @seedytx19 | X | XXXXX | X | XX |
| @semodough | X | XXXXXX | X | XX |
| @Anders_Research | X | XXXXX | X | XX |
| @Pelegggg | X | XX | X | XX |
| @Quantumup1 | XX | XXXXX | X | XX |
Sentiment: XX%
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% +11%
X Month: XX% +24%
X Months: XX% +27%
X Year: XX% +8%
1-Year High: XXX% on 2025-07-13
1-Year Low: XX% on 2025-09-18
Most Supportive Themes:
- Analyst Coverage: (40%) Analysts are increasing their target prices and initiating buy ratings for Arcellx, Inc.
- FDA Pre-BLA Meeting & 2026 Launch Plan: (30%) Arcellx has completed a pre-BLA meeting with the FDA, confirming their 2026 launch plan for anito-cel.
- Phase X Data Presentation: (20%) Arcellx will present Phase X multiple myeloma results for anitocabtagene autoleucel at ASH 2025.
Most Critical Themes:
- Lower Engagement: (10%) Despite positive sentiment, overall engagement is lower than the daily average.
Social Dominance: XXXXX%
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.015%
X Month: XXXXX% +0.023%
X Months: XXXXX% +0.017%
X Year: XXXXX% -XXXXX%
1-Year High: XXXXX% on 2024-12-21
1-Year Low: XXXXXX% on 2025-09-15
Market Dominance: XXXXXXX%
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXX% on 2025-11-23
1-Year Low: XXXXXXX% on 2025-12-11
Market Cap: $XXXXXXXXXXXXX
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX +$6.70%
X Month: $XXXXXXXXXXXXX -$19%
X Months: $XXXXXXXXXXXXX +$16%
X Year: $XXXXXXXXXXXXX -$10%
1-Year High: $XXXXXXXXXXXXX on 2025-11-17
1-Year Low: $XXXXXXXXXXXXX on 2025-05-06
Top Arcellx, Inc. Common Stock Social Posts
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"$ACLX $ACM ⚠👀 Guys Don't miss the next move in a few hours 💸➡"
X Link @KallolKalo88348 2025-12-11T19:52Z XX followers, X engagements
"Arcellx 8-K: My Take on Promising Cancer Therapy Data"
YouTube Link @CorporateDecoder 2025-12-11T18:31Z 3250 followers, X engagements
"New data from Gilead Arcellx multiple myeloma CAR-T suggest benefit over rival treatment via @statnews #healthcare"
X Link @MailMyStatement 2025-12-10T21:30Z 6000 followers, XX engagements
"Long-term buying opportunities worth paying attention to: $HIMS $OSCR $BULL $PATH $SOUN $NVO $UNH $GLXY $WOLF $DFDV $NXTT $QUBT $DRUG $RGC $BTQ $SLB $HAL $OXY $COP $PXD $RIC $RDNT $GNE $AXSM $IDYA $KYMR $BRZE $SYRE $DENLI $XENE $RIOT $RNA $ACLX $GILD $BIO"
X Link @SMALLCAPSAXIS 2025-12-10T20:00Z XXX followers, 1075 engagements